Genomics England

Powering genomic medicine, together

Hybrid

Some members of the team work remotely, while others are co-located in one or more offices.

💼Healthcare

👥51-200

📍London, United Kingdom

Genomics England

About Genomics England

Genomics England is a wholly owned company of the Department of Health set up to deliver the 100,000 Genomes Project.

What Genomics England is building

Genomics is a ground-breaking area of medicine that uses our unique genetic code to help diagnose, treat and prevent illnesses. Thanks to advanced technology, scientists can now compare many people’s genetic code to make new discoveries that continually improve genomic healthcare.

Technologies used at Genomics England

Back-end (4)

Python

SQL

Java

NoSQL

Company culture

Speed

We take an agile and iterative approach to everything – not just software development – seeking to share and get input constantly.

Empathy

Patients are the priority, so we ensure quality and relevance in our outputs, and put their interests ahead of our own.

Funding rounds

Company type

For Profit

Genomics England news and updates

Genomics England Limited is developing cutting-edge genome analysis approaches for diverse clinical applications

The Genome Analysis team at Genomics England are working to develop cutting-edge genome analysis approaches for diverse clinical applications.

Dec 1, 2022 | genomicsengland.co.uk

Oxford Nanopore Technologies Ltd partners with Genomics England Limited

Oxford Nanopore announced the next steps in its collaboration with Genomics England, which is using nanopore technology in an ongoing proof-of-concept project to evaluate the clinical and research applications of comprehensive genomic analysis of cancer tumours.

Jan 1, 2022 | mailchi.mp

Genomics England Limited expands offices to London’s Canary Wharf

Genomics England, a global leader in advancing and delivering genomic medicine and genomic research, is moving its headquarters to London’s Canary Wharf during autumn, following the announcement in March of a joint venture by Canary Wharf Group (CWG) and Kadans Science Partner to develop a life science focused laboratory on the London site, as the first phase of plans for a leading health and life sciences cluster.

Jan 1, 2022 | labmate-online.com